SPEAR Immunoassays for Neurodegenerative Biomarker Detection & Monitoring
9:00 am - Wednesday 3rd June 2026
- A novel immunoassay platform enabling ultra-sensitive detection of low-abundance neurological biomarkers in blood
- Advancing translational and clinical research through high sensitivity, specificity, and precision across challenging neurodegenerative biomarkers
- Expanding beyond established biomarkers with custom assay development to support biomarker-driven therapeutic development
